From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

An orally available small molecule, mutant-selective inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Olmutinib binds to and inhibits mutant forms of EGFR, thereby leading to cell death of EGFR-expressing tumor cells. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced as compared to non-selective EGFR inhibitors which also inhibit the EGFR wild type form.

Learn more about Olmutinib

Latest research - Olmutinib

Clinical trials

External links

Medicine icon
Medicine icon

This WikiMD article Olmutinib is a stub. If you are familiar with the topic Olmutinib, you can help us. Paid editors welcome!


Olmutinib is part of WikiMD's free ^articles!

^Olmutinib (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Overweight?. W8MD's physician weight loss & sleep medicine program can HELP. Philadelphia lose weight. NYC lose weight Tele weight loss available